Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) is a brand-name inhaler that’s prescribed for COPD. This article covers topics such as side effects, dosage ...

Trelegy Ellipta got its first US approval in September as a daily long-term maintenance therapy for chronic obstructive pulmonary disease (COPD). Trelegy was approved in Europe last week in COPD ...

The FDA has approved an expanded label for GlaxoSmithKline’s new Trelegy Ellipta inhaler, allowing it to be used in a broader population of patients with chronic obstructive pulmonary disease ...

That includes the company's popular Trelegy Ellipta and other Ellipta inhaler products, among others. The caps come after GSK ...

Fluticasone furoate, umeclidinium, vilanterol 100/62.5/25mcg, 200/62.5/25mcg; per inh; dry pwd for oral inhalation. Trelegy Ellipta is supplied as a disposable light grey and beige plastic inhaler ...